(Q51526875)

6 April 2018

title

Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. (English)

1 reference

6 April 2018

inflammatory bowel diseases

main subject

0 references

1 reference

1 reference

2

1 reference

6 April 2018

Willem de Vos

4

object named as

Willem M de Vos

1 reference

6 April 2018

author name string

Kaija-Leena Kolho

1

1 reference

6 April 2018

Tytti Jaakkola

3

1 reference

6 April 2018

Vidya Velagapudi

5

1 reference

6 April 2018

publication date

8 September 2016

1 reference

6 April 2018

Journal of Crohn's and Colitis

published in

1 reference

6 April 2018

volume

11

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

321-334

1 reference

6 April 2018

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Specificities of inflammatory bowel disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

The treatment-naive microbiome in new-onset Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Proteomics and metabolomics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Metabolomics: is it useful for inflammatory bowel diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Vitamin B₁₂-dependent taurine synthesis regulates growth and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

MetaboAnalyst: a web server for metabolomic data analysis and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Mucosal barrier in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Metabolic regulation in progression to autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

The gut microbiota modulates host energy and lipid metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW158

21 January 2018

Identifiers

DOI

10.1093/ECCO-JCC/JJW158

1 reference

6 April 2018

1 reference

6 April 2018